Exercise tolerance before and after correction of anemia with epoetin alfa
Lacina, N.C.
American Journal of Kidney Diseases the Official Journal of the National Kidney Foundation 17(2): 245
1991
ISSN/ISBN: 0272-6386 PMID: 1992671 Document Number: 370629
Document emailed within 1 workday
Related Documents
Faris, P.M.; Ritter, M.A. 1998: Epoetin alfa. a bloodless approach for the treatment of perioperative anemia Clinical Orthopaedics and Related Research 357: 60-67Rieger, P.T.; Haeuber, D. 1995: A new approach to managing chemotherapy-related anemia: nursing implications of epoetin alfa Oncology Nursing Forum 22(1): 71-81
Thanakitcharu, P.; Siriwiwatanakul, N. 2007: Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia Journal of the Medical Association of Thailand 90(12): 2574-2586
Voravud, N.; Sriuranpong, V. 2005: Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy Journal of the Medical Association of Thailand 88(5): 607-612
1989: Epoetin alfa: patient management Anna Journal 16(5): 348-350
Bachmann, G.A. 2001: Epoetin alfa use in gynecology. Past, present and future Journal of Reproductive Medicine 46(5 Suppl): 539-544
Bieber, E. 2001: Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview Journal of Reproductive Medicine 46(5 Suppl): 521-530
Kammerer, J.K. 1994: Case study of the anemic patient: epoetin alfa--focus on protocols Anna Journal 21(7): 440-443
Keen, M.L. 1990: Case management of the anemic patient. Epoetin alfa: focus on kinetic dosing Anna Journal 17(4): 318-319
Morley, C.T. 1993: Case management of the anemic patient: epoetin alfa--focus on osteitis fibrosa Anna Journal 20(5): 604-607
Shanahan, M.; Walton, S. 1995: Developing an epoetin alfa medication protocol to improve patient care and foster collaboration Anna Journal 22(5): 471-476
Martin-Lester, M. 1996: Epoetin alfa--focus on the rehabilitation of dialysis patients. Case study of the anemic patient Anna Journal 23(6): 630-633
Cohen, J.A.; Brattich, M. 1997: Epoetin alfa: focus on maintaining a higher, stable, Hct. Case study of the anemic patient Anna Journal 24(5): 574-580; Quiz 581
Cohen, J.A.; Brattich, M. 1997: Epoetin alfa: focus on maintaining a higher, stable, Hct. Case study of the anemic patient Anna Journal 24(5): 574-580; Quiz 581
Voravud, N.; Sriuranpong, V.; Suwanrusme, H. 2007: Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy Journal of the Medical Association of Thailand 90(6): 1082-1088
Campistol, J.M.; Carreño, Aín.; Morales, Jé.M.; Pallardó, L.; Franco, A.; Navarro, D.; Grinyó, J.M.; Montenegro, Jús.; Sánchez Fructuoso, A.I.; Romero, Rón.; Guirado, L.; Arias, M.; Nieto-Iglesias, J.; Esforzado, N.; Beltrán-Catalán, S.; Gómez-Alamillo, C.; Lauzurica, R.; Bengoa, I.; Facundo-Molas, C. 2013: Once-monthly pegylated epoetin Beta versus darbepoetin alfa every two weeks in renal transplant recipients: a randomized trial Transplantation 95(2): E6
Ashrani, A.A.; Rajkumar, S.Vincent. 2007: Chronic kidney disease, anemia, and epoetin New England Journal of Medicine 356(9): 957
Roger, S.D. 2007: Chronic kidney disease, anemia, and epoetin New England Journal of Medicine 356(9): 958; Author Reply 958-959
Mikhail, A.; Goldsmith, D. 2007: Chronic kidney disease, anemia, and epoetin New England Journal of Medicine 356(9): 956
Veys, N.; Dhondt, A.; Lameire, N. 1998: Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta Clinical Nephrology 49(1): 41-44